Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00914069 · ClinicalTrials.gov registry record · NA
Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
A NA study, sponsored by C. R. Bard.
- Terminated
- Registry status
- NA
- Development phase
- 175
- Enrollment target
NCT00914069: Clinical Trial NA study, sponsored by C. R. Bard.
NCT00914069 is a NA study that was terminated before completion, run by C. R. Bard. The registered enrollment target is 175 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00914069, a NA study, was terminated before completion, sponsored by C. R. Bard.
- TERMINATED
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
Study Summary
The study will test a hypothesis that the RIVS system will have a higher rate of successful first PIV placement compared to conventional catheter without a significant increase in complications and time of procedure.
Primary Outcome
A successful IV insertion includes all of the following: initial vein penetration, which is visualized by a flash back of blood into the access device, deployment of the guidewire, advancement of the catheter into the vein, retraction of needle and guidewire, and flushing of IV. A secured flushed IV will be indicative of a successful PIV placement.
Interventions
- DEVICE RIVS vascular access
- DEVICE Conventional vascular access
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-08 |
| Phase | NA |
Why NCT00914069 stopped before completion
NCT00914069 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which RIVS vascular access is the first listed.
NCT00914069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00914069 about?
NCT00914069 is a clinical study titled "Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter". The study will test a hypothesis that the RIVS system will have a higher rate of successful first PIV placement compared to conventional catheter without a significant increase in complications and time of procedure.
What is the current status of trial NCT00914069?
This trial is currently terminated. It is a NA study. The enrollment target is 175 participants. The study started on 2009-06. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00914069?
The interventions under investigation include: RIVS vascular access (DEVICE), Conventional vascular access (DEVICE).
Who is sponsoring clinical trial NCT00914069?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00914069's enrollment target sits among peer trials
175 610th of 2000 higher than 1,391 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia